<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Arch Med Sci</journal-id><journal-id journal-id-type="publisher-id">AMS</journal-id><journal-title-group><journal-title>Archives of Medical Science : AMS</journal-title></journal-title-group><issn pub-type="ppub">1734-1922</issn><issn pub-type="epub">1896-9151</issn><publisher><publisher-name>Termedia Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23847666</article-id><article-id pub-id-type="pmc">3701980</article-id><article-id pub-id-type="publisher-id">20876</article-id><article-id pub-id-type="doi">10.5114/aoms.2013.35343</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Manual lymphatic drainage improves the quality of life in patients with chronic venous disease: a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Molski</surname><given-names>Pawel</given-names></name><xref ref-type="aff" rid="AF0001">1</xref><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Kruczyński</surname><given-names>Jacek</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Molski</surname><given-names>Andrzej</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Molski</surname><given-names>Stanislaw</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Department of Physiotherapy, Eskulap Health Centre, Bydgoszcz, Poland</aff><aff id="AF0002"><label>2</label>Department of General Orthopaedics, Musculoskeletal Oncology and Trauma Surgery, Poznan University of Medical Sciences, Poznan, Poland</aff><aff id="AF0003"><label>3</label>Department of Vascular Surgery, Eskulap Health Centre, Bydgoszcz, Poland</aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Pawel Molski PT, PhD, Department of Physiotherapy, Eskulap Health Centre, 41 Cicha St, 85-650 Bydgoszcz, Poland. Phone: +48 502 021 260, Fax: +48 (52) 360 23 56. E-mail: <email xlink:href="p.molski@szpitaleskulap.pl">p.molski@szpitaleskulap.pl</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>5</month><year>2013</year></pub-date><pub-date pub-type="ppub"><day>20</day><month>6</month><year>2013</year></pub-date><volume>9</volume><issue>3</issue><fpage>452</fpage><lpage>458</lpage><history><date date-type="received"><day>07</day><month>7</month><year>2011</year></date><date date-type="rev-recd"><day>22</day><month>8</month><year>2011</year></date><date date-type="accepted"><day>02</day><month>10</month><year>2011</year></date></history><permissions><copyright-statement>Copyright © 2013 Termedia &amp; Banach</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3674" xml_f="3686" txt_i="11" txt_f="23">Introduction</offsets></title><p><offsets xml_i="3697" xml_f="4015" txt_i="24" txt_f="342">Manual lymphatic drainage (MLD) is an adjunctive method of chronic venous disease (CVD) therapy. Evaluation of the change at the clinical stage, hemodynamic parameters and quality of life (QoL) following venous system surgery in CVD patients undergoing MLD preoperatively are the most interesting aspects of the study.</offsets></p></sec><sec id="st2"><title><offsets xml_i="4046" xml_f="4066" txt_i="344" txt_f="364">Material and methods</offsets></title><p><offsets xml_i="4077" xml_f="4198" txt_i="365" txt_f="486">The CVD patients qualified for elective surgery of the venous system were randomly divided into 2 groups: the MLD group (</offsets><italic><offsets xml_i="4206" xml_f="4207" txt_i="486" txt_f="487">n</offsets></italic><offsets xml_i="4216" xml_f="4246" txt_i="487" txt_f="517"> = 38) and the control group (</offsets><italic><offsets xml_i="4254" xml_f="4255" txt_i="517" txt_f="518">n</offsets></italic><offsets xml_i="4264" xml_f="4770" txt_i="518" txt_f="1024"> = 32). In the preoperative period, the MLD group underwent a series of MLD through a period of 2 weeks. The control group did not undergo MLD preoperatively. Both groups were evaluated for CVD staging on the day of qualification for surgery and between 25 and 30 days post-operatively. Additionally, the MLD group was evaluated after the series of MLD. The CVD staging was evaluated in both groups with a QoL questionnaire (CIVIQ), CEAP classification, foot volumetry (FV) and venous refilling time (VRT).</offsets></p></sec><sec id="st3"><title><offsets xml_i="4801" xml_f="4808" txt_i="1026" txt_f="1033">Results</offsets></title><p><offsets xml_i="4819" xml_f="5289" txt_i="1034" txt_f="1504">Parameter values obtained in the MLD group (before treatment/after MLD/after surgery): CEAP 2.23/2.15/2.10, VRT 15/13/15.6, FV 3625/3472/3418, CIVIQ-complaints: 54.4/43.8/38.2 and CIVIQ-meaning: 57.3/49.3/43.1. Parameter values obtained in control group (before surgery/after surgery): CEAP 2.4/2.12, VRT 13/14.9, FV 3581/3559, CIVIQ-complaints: 51.9/38.7 and CIVIQ-meaning: 53.7/40.6. The CVD patients statistically improved in CEAP staging, FV and QoL in both groups (</offsets><italic><offsets xml_i="5297" xml_f="5298" txt_i="1504" txt_f="1505">p</offsets></italic><offsets xml_i="5307" xml_f="5319" txt_i="1505" txt_f="1514"> &lt; 0.05).</offsets></p></sec><sec id="st4"><title><offsets xml_i="5350" xml_f="5361" txt_i="1516" txt_f="1527">Conclusions</offsets></title><p><offsets xml_i="5372" xml_f="5647" txt_i="1528" txt_f="1803">The MLD alone significantly reduced FV in patients with CVD, also improving their QoL. The MLD applied in CVD patients at the preoperative stage results in better surgical outcome, which is demonstrated by reduced disease progression, FV reduction and improvement in the QoL.</offsets></p></sec></abstract><kwd-group><kwd>manual lymphatic drainage</kwd><kwd>chronic venous disease</kwd><kwd>quality of life</kwd></kwd-group></article-meta></front><body><sec id="S0001"><title><offsets xml_i="5838" xml_f="5850" txt_i="1812" txt_f="1824">Introduction</offsets></title><p><offsets xml_i="5861" xml_f="6516" txt_i="1825" txt_f="2480">Chronic venous disease (CVD) is a condition that leads to significant somatic symptoms, which may cause psychological disorders and difficulties in the field of social activity. Until recently, research on the effects of treatment in patients with CVD focused mainly on the functional condition and the influence of physiotherapy on the level of physical fitness. Intensive development of studies on quality of life (QoL) in medical sciences provided an opportunity to evaluate the QoL in patients with CVD. It seems to be a useful diagnostic method, which contributes to the evaluation of disease severity, as well as to evaluation of treatment effects [</offsets><xref ref-type="bibr" rid="CIT0001"><offsets xml_i="6552" xml_f="6553" txt_i="2480" txt_f="2481">1</offsets></xref><offsets xml_i="6560" xml_f="6561" txt_i="2481" txt_f="2482">–</offsets><xref ref-type="bibr" rid="CIT0004"><offsets xml_i="6597" xml_f="6598" txt_i="2482" txt_f="2483">4</offsets></xref><offsets xml_i="6605" xml_f="6607" txt_i="2483" txt_f="2485">].</offsets></p><p><offsets xml_i="6614" xml_f="7163" txt_i="2486" txt_f="3035">One of the methods of conservative treatment of CVD is manual lymphatic drainage (MLD). However, this method is rarely used in patients with venous insufficiency. Therefore, it seems to be justified to commence research on the use of MLD in patients with CVD. The aim of the study was to evaluate the influence of MLD on clinical staging, QoL and hemodynamic parameters in CVD patients, as well as changes in clinical manifestation, hemodynamic parameters and QoL after varicose vein surgery in patients who underwent a series of MLD before surgery.</offsets></p></sec><sec sec-type="materials|methods" id="S0002"><title><offsets xml_i="7225" xml_f="7245" txt_i="3037" txt_f="3057">Material and methods</offsets></title><p><offsets xml_i="7256" xml_f="8228" txt_i="3058" txt_f="4030">The study included 216 consecutive patients with a diagnosis of CVD, qualified for elective surgery and compression therapy for this reason. The study was conducted in the Eskulap Phlebology Centre in Bydgoszcz. Inclusion criteria were CEAP stage C2 and C3, patient willing to undergo elective stripping of the great saphenous vein (GSV), and consent for the study. Exclusion criteria: not willing to undergo surgery, incompetence of deep venous system described as a reflux longer than 0.5 s, chronic lower limb ischemia defined as a lack of distal pulses or signs of ambulatory claudication Fontaine grade II to IV, skin infection, severe comorbidities described as ASA grade III to V, presence of neoplastic disease, lymphangitis, heart failure and renal failure. The study included 80 patients aged from 25 to 65, 70 women (average age 50 years) and 10 men (average age 49 years) with CVD stage CEAP C2 or C3, who were randomly divided into two groups: the MLD group (</offsets><italic><offsets xml_i="8236" xml_f="8237" txt_i="4030" txt_f="4031">n</offsets></italic><offsets xml_i="8246" xml_f="8276" txt_i="4031" txt_f="4061"> = 38) and the control group (</offsets><italic><offsets xml_i="8284" xml_f="8285" txt_i="4061" txt_f="4062">n</offsets></italic><offsets xml_i="8294" xml_f="8744" txt_i="4062" txt_f="4512"> = 32). The randomization was conducted using 40 sealed envelopes which directed patients to the MLD group and 40 envelopes that directed patients to the control group. In order to randomize a pa-tient's choice of one of the remaining envelopes, open envelopes were discarded. Two patients from the MLD group and 8 from the control group were lost to follow-up and excluded from the study. The study was performed according to the study's algorithm (</offsets><xref ref-type="fig" rid="F0001"><offsets xml_i="8777" xml_f="8785" txt_i="4512" txt_f="4520">Figure 1</offsets></xref><offsets xml_i="8792" xml_f="8794" txt_i="4520" txt_f="4522">).</offsets></p><fig id="F0001" position="float"><label><offsets xml_i="8838" xml_f="8846" txt_i="4523" txt_f="4531">Figure 1</offsets></label><caption><p><offsets xml_i="8866" xml_f="8903" txt_i="4531" txt_f="4568">The algorithm of the research process</offsets></p></caption><graphic xlink:href="AMS-9-20876-g001"></graphic></fig><fig id="F0002" position="float"><label><offsets xml_i="9012" xml_f="9020" txt_i="4569" txt_f="4577">Figure 2</offsets></label><caption><p><offsets xml_i="9040" xml_f="9119" txt_i="4577" txt_f="4656">Comparison of average values of clinical stage according to CEAP classification</offsets></p></caption><graphic xlink:href="AMS-9-20876-g002"></graphic></fig><p><offsets xml_i="9191" xml_f="9584" txt_i="4657" txt_f="5050">Qualification for elective GSV stripping due to CVD was based on clinical evaluation and lower extremities venous system ultrasound duplex examination performed by a vascular surgeon with 30 years’ experience. The qualification criteria for elective GSV stripping were clinical signs of CVD and presence of GSV reflux longer than 0.5 s following a Valsalva maneuver or distal vein compression.</offsets></p><p><offsets xml_i="9591" xml_f="9716" txt_i="5051" txt_f="5176">The study group was made up of 38 patients with CVD, qualified for surgery, who had preoperatively undergone a series of MLD.</offsets></p><p><offsets xml_i="9723" xml_f="9821" txt_i="5177" txt_f="5275">The MLD included the CVD limb affected and it was performed according to the technique of Vodder [</offsets><xref ref-type="bibr" rid="CIT0005"><offsets xml_i="9857" xml_f="9858" txt_i="5275" txt_f="5276">5</offsets></xref><offsets xml_i="9865" xml_f="10107" txt_i="5276" txt_f="5518">]. Each person in the study group underwent a series of 10 MLD. Each procedure was performed 5 times a week for 20 mins. The control group included 42 patients with CVD, who had been qualified for surgery without undergoing the series of MLD.</offsets></p><p><offsets xml_i="10114" xml_f="10361" txt_i="5519" txt_f="5766">All randomized patients underwent the following: clinical evaluation according to CEAP classification complemented with scale of pathological changes severity, photoplethysmography, foot volumetry, QOL examination according to civiq questionnaire.</offsets></p><p><offsets xml_i="10368" xml_f="10650" txt_i="5767" txt_f="6049">One day after the last series of MLD, the patients from the study group underwent: clinical examination according to CEAP classification complemented with scale of pathological changes severity, photoplethysmography, foot volumetry, QoL examination according to CIVIQ questionnaire.</offsets></p><p><offsets xml_i="10657" xml_f="10812" txt_i="6050" txt_f="6205">All patients included in the control group, as well as those in the study group, underwent elective venous surgery due to CVD and were recommended to use 2</offsets><sup><offsets xml_i="10817" xml_f="10819" txt_i="6205" txt_f="6207">nd</offsets></sup><offsets xml_i="10825" xml_f="10853" txt_i="6207" txt_f="6235"> degree compression therapy.</offsets></p><p><offsets xml_i="10860" xml_f="12350" txt_i="6236" txt_f="7726">Surgery in both groups started from venous system mapping by duplex-Doppler USG. First, perforating and deep system competence and patency were evaluated. Next, main superficial trunks incompetence and level of venous reflux were evaluated. Surgery of the incompetent GSV was started in the groin with a skin incision located in the inguinal crease. The sapheno-femoral junction (SFJ) was dissected. The GSV was ligated and cut as close as possible to the common femoral vein (CFV) but without leaving a CFV stricture. All collateral veins of the SFJ were ligated and cut. The sapheno-popliteal junction was dissected at the level marked during USG mapping. The small saphenous vein (SSV) was ligated in the place where it pierced the muscular fascia in order to join the popliteal vein. The distal part of the GSV or SSV was stripped in the whole incompetent part with a Babcock stripper. Any major varicose collaterals were removed by mini-phlebectomy with use of an Oesch hook. Skin wounds were sutured and sterile dressing and compression bandages were applied. All patients were discharged the next day post-operatively and scheduled for a follow-up visit after 7 days. Patients received the recommendation to use compression therapy and oral pain killer medication (ketoprofen 3 × 100 mg). During post-operative visits patients were evaluated for possible adverse events. Except for mild thigh bruising and tenderness, no adverse events were observed during the post-operative period.</offsets></p><p><offsets xml_i="12357" xml_f="12659" txt_i="7727" txt_f="8029">One month after the surgery, the patients underwent a follow-up examination, which consisted of: clinical examination according to the CEAP classification complemented with a scale of pathological changes severity, photoplethysmography, foot volumetry, QoL examination according to CIVIQ questionnaire.</offsets></p><sec id="S20003"><title><offsets xml_i="12687" xml_f="12700" txt_i="8030" txt_f="8043">Data analysis</offsets></title><p><offsets xml_i="12711" xml_f="13129" txt_i="8044" txt_f="8462">At the first stage of statistical proceedings, the Shapiro-Wilk test was performed to determine whether the distribution of the studied quantitative parameters (venous refilling time, foot volumetry and QoL) followed a normal distribution. As the distribution of the parameters did not follow a normal distribution, later on in the course of statistical procedures, nonparametric tests were applied, i.e. Mann-Whitney </offsets><italic><offsets xml_i="13137" xml_f="13138" txt_i="8462" txt_f="8463">U</offsets></italic><offsets xml_i="13147" xml_f="13631" txt_i="8463" txt_f="8947">-test and Wilcoxon matched pairs test. The first test was used to compare the control group with the study group in terms of foot volumetry and QoL, whereas the Wilcoxon matched pairs test was carried out to evaluate the significance of differences between the values of particular measurements obtained on the day of qualification and after MLD was carried out. The statistical influence of the group and of the administered therapy on ordinal features was examined by means of the χ</offsets><sup><offsets xml_i="13636" xml_f="13637" txt_i="8947" txt_f="8948">2</offsets></sup><offsets xml_i="13643" xml_f="13666" txt_i="8948" txt_f="8971"> test for independence.</offsets></p></sec></sec><sec sec-type="results" id="S0004"><title><offsets xml_i="13724" xml_f="13731" txt_i="8974" txt_f="8981">Results</offsets></title><sec id="S20005"><title><offsets xml_i="13763" xml_f="13800" txt_i="8982" txt_f="9019">Clinical disease severity measurement</offsets></title><p><offsets xml_i="13811" xml_f="13992" txt_i="9020" txt_f="9201">On the day of qualification, the average degree of severity in the study group according to CEAP was 2.23. After MLD the average value of the clinical CEAP score decreased to 2.15 (</offsets><italic><offsets xml_i="14000" xml_f="14001" txt_i="9201" txt_f="9202">p</offsets></italic><offsets xml_i="14010" xml_f="14099" txt_i="9202" txt_f="9288"> &lt; 0.05). In the MLD group after surgery the average value of CEAP decreased to 2.10 (</offsets><italic><offsets xml_i="14107" xml_f="14108" txt_i="9288" txt_f="9289">p</offsets></italic><offsets xml_i="14117" xml_f="14237" txt_i="9289" txt_f="9406"> &lt; 0.05). The clinical picture improved also in the control group, where the CEAP score decreased from 2.40 to 2.12 (</offsets><italic><offsets xml_i="14245" xml_f="14246" txt_i="9406" txt_f="9407">p</offsets></italic><offsets xml_i="14255" xml_f="14382" txt_i="9407" txt_f="9531"> &lt; 0.05). After surgery no statistically significant differences between the MLD group and the control group were observed (</offsets><xref ref-type="fig" rid="F0001"><offsets xml_i="14415" xml_f="14423" txt_i="9531" txt_f="9539">Figure 1</offsets></xref><offsets xml_i="14430" xml_f="14432" txt_i="9539" txt_f="9541">).</offsets></p></sec><sec id="S20006"><title><offsets xml_i="14466" xml_f="14492" txt_i="9543" txt_f="9569">Pain intensity measurement</offsets></title><p><offsets xml_i="14503" xml_f="14587" txt_i="9570" txt_f="9654">In the MLD group, after a series of MLD, pain symptoms decreased from 0.95 to 0.08 (</offsets><italic><offsets xml_i="14595" xml_f="14596" txt_i="9654" txt_f="9655">p</offsets></italic><offsets xml_i="14605" xml_f="14698" txt_i="9655" txt_f="9745"> &lt; 0.05). The intensity of pain decreased in both groups in the course of the experiment (</offsets><xref ref-type="table" rid="T0001"><offsets xml_i="14733" xml_f="14740" txt_i="9745" txt_f="9752">Table I</offsets></xref><offsets xml_i="14747" xml_f="14864" txt_i="9752" txt_f="9869">). After surgery no statistically significant differences between the MLD group and the control group were observed.
</offsets></p><table-wrap id="T0001" position="float"><label><offsets xml_i="14915" xml_f="14922" txt_i="9870" txt_f="9877">Table I</offsets></label><caption><p><offsets xml_i="14942" xml_f="14981" txt_i="9877" txt_f="9916">Pain intensity in control and MLD group</offsets></p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="15143" xml_f="15149" txt_i="9917" txt_f="9923">0 – No</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="15197" xml_f="15209" txt_i="9923" txt_f="9935">1 – Moderate</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="15257" xml_f="15267" txt_i="9935" txt_f="9945">2 – Strong</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="15315" xml_f="15330" txt_i="9945" txt_f="9960">3 – Very strong</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="15378" xml_f="15383" txt_i="9960" txt_f="9965">Total</offsets></th></tr></thead><tbody><tr><td colspan="6" align="left" rowspan="1"><offsets xml_i="15453" xml_f="15454" txt_i="9965" txt_f="9966">
</offsets><bold><offsets xml_i="15460" xml_f="15469" txt_i="9966" txt_f="9975">MLD group</offsets></bold><offsets xml_i="15476" xml_f="15477" txt_i="9975" txt_f="9976">
</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="15532" xml_f="15559" txt_i="9977" txt_f="10004">On the day of qualification</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15607" xml_f="15617" txt_i="10005" txt_f="10015">7 (18.42%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15665" xml_f="15676" txt_i="10016" txt_f="10027">27 (71.05%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15724" xml_f="15733" txt_i="10028" txt_f="10037">3 (7.89%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15781" xml_f="15790" txt_i="10038" txt_f="10047">1 (2.63%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15838" xml_f="15840" txt_i="10048" txt_f="10050">38</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="15895" xml_f="15908" txt_i="10051" txt_f="10064">After surgery</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15956" xml_f="15967" txt_i="10065" txt_f="10076">33 (86.84%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16015" xml_f="16025" txt_i="10077" txt_f="10087">5 (13.16%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16073" xml_f="16079" txt_i="10088" txt_f="10094">0 (0%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16127" xml_f="16133" txt_i="10095" txt_f="10101">0 (0%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16181" xml_f="16183" txt_i="10102" txt_f="10104">38</offsets></td></tr><tr><td colspan="6" align="left" rowspan="1"><offsets xml_i="16238" xml_f="16239" txt_i="10105" txt_f="10106">
</offsets><bold><offsets xml_i="16245" xml_f="16258" txt_i="10106" txt_f="10119">Control group</offsets></bold><offsets xml_i="16265" xml_f="16266" txt_i="10119" txt_f="10120">
</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="16321" xml_f="16348" txt_i="10121" txt_f="10148">On the day of qualification</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16396" xml_f="16406" txt_i="10149" txt_f="10159">4 (12.50%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16454" xml_f="16465" txt_i="10160" txt_f="10171">23 (71.88%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16513" xml_f="16523" txt_i="10172" txt_f="10182">5 (15.63%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16571" xml_f="16577" txt_i="10183" txt_f="10189">0 (0%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16625" xml_f="16627" txt_i="10190" txt_f="10192">32</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="16682" xml_f="16695" txt_i="10193" txt_f="10206">After surgery</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16743" xml_f="16754" txt_i="10207" txt_f="10218">29 (90.63%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16802" xml_f="16811" txt_i="10219" txt_f="10228">3 (9.38%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16859" xml_f="16865" txt_i="10229" txt_f="10235">0 (0%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16913" xml_f="16919" txt_i="10236" txt_f="10242">0 (0%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16967" xml_f="16969" txt_i="10243" txt_f="10245">32</offsets></td></tr></tbody></table></table-wrap></sec><sec id="S20007"><title><offsets xml_i="17038" xml_f="17065" txt_i="10247" txt_f="10274">Edema intensity measurement</offsets></title><p><offsets xml_i="17076" xml_f="17176" txt_i="10275" txt_f="10375">In the MLD group after a series of MLD, a delay in occurrence of edema during the day was observed (</offsets><italic><offsets xml_i="17184" xml_f="17185" txt_i="10375" txt_f="10376">p</offsets></italic><offsets xml_i="17194" xml_f="17279" txt_i="10376" txt_f="10458"> &lt; 0.05). Also in both groups edema was observed later regarding the time of day (</offsets><italic><offsets xml_i="17287" xml_f="17288" txt_i="10458" txt_f="10459">p</offsets></italic><offsets xml_i="17297" xml_f="17410" txt_i="10459" txt_f="10569"> &lt; 0.05). No statistically significant differences between the MLD group and the control group were observed (</offsets><xref ref-type="table" rid="T0002"><offsets xml_i="17445" xml_f="17453" txt_i="10569" txt_f="10577">Table II</offsets></xref><offsets xml_i="17460" xml_f="17463" txt_i="10577" txt_f="10580">).
</offsets></p><table-wrap id="T0002" position="float"><label><offsets xml_i="17514" xml_f="17522" txt_i="10581" txt_f="10589">Table II</offsets></label><caption><p><offsets xml_i="17542" xml_f="17609" txt_i="10589" txt_f="10656">Comparison of time of occurrence of edema regarding the time of day</offsets></p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="17771" xml_f="17777" txt_i="10657" txt_f="10663">0 – No</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="17825" xml_f="17836" txt_i="10663" txt_f="10674">1 – Evening</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="17884" xml_f="17897" txt_i="10674" txt_f="10687">2 – Afternoon</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="17945" xml_f="17956" txt_i="10687" txt_f="10698">3 – Morning</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="18004" xml_f="18009" txt_i="10698" txt_f="10703">Total</offsets></th></tr></thead><tbody><tr><td colspan="6" align="left" rowspan="1"><offsets xml_i="18079" xml_f="18080" txt_i="10703" txt_f="10704">
</offsets><bold><offsets xml_i="18086" xml_f="18095" txt_i="10704" txt_f="10713">MLD group</offsets></bold><offsets xml_i="18102" xml_f="18103" txt_i="10713" txt_f="10714">
</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="18158" xml_f="18185" txt_i="10715" txt_f="10742">On the day of qualification</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18233" xml_f="18244" txt_i="10743" txt_f="10754">11 (28.95%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18292" xml_f="18303" txt_i="10755" txt_f="10766">16 (42.11%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18351" xml_f="18361" txt_i="10767" txt_f="10777">7 (18.42%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18409" xml_f="18419" txt_i="10778" txt_f="10788">4 (10.53%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18467" xml_f="18469" txt_i="10789" txt_f="10791">38</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="18524" xml_f="18537" txt_i="10792" txt_f="10805">After surgery</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18585" xml_f="18596" txt_i="10806" txt_f="10817">32 (84.21%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18644" xml_f="18654" txt_i="10818" txt_f="10828">5 (13.16%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18702" xml_f="18711" txt_i="10829" txt_f="10838">1 (2.63%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18759" xml_f="18765" txt_i="10839" txt_f="10845">0 (0%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18813" xml_f="18815" txt_i="10846" txt_f="10848">38</offsets></td></tr><tr><td colspan="6" align="left" rowspan="1"><offsets xml_i="18870" xml_f="18871" txt_i="10849" txt_f="10850">
</offsets><bold><offsets xml_i="18877" xml_f="18890" txt_i="10850" txt_f="10863">Control group</offsets></bold><offsets xml_i="18897" xml_f="18898" txt_i="10863" txt_f="10864">
</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="18953" xml_f="18980" txt_i="10865" txt_f="10892">On the day of qualification</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19028" xml_f="19038" txt_i="10893" txt_f="10903">8 (25.00%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19086" xml_f="19097" txt_i="10904" txt_f="10915">12 (37.50%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19145" xml_f="19156" txt_i="10916" txt_f="10927">10 (31.25%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19204" xml_f="19213" txt_i="10928" txt_f="10937">2 (6.25%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19261" xml_f="19263" txt_i="10938" txt_f="10940">32</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="19318" xml_f="19331" txt_i="10941" txt_f="10954">After surgery</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19379" xml_f="19390" txt_i="10955" txt_f="10966">25 (78.13%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19438" xml_f="19448" txt_i="10967" txt_f="10977">4 (12.50%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19496" xml_f="19505" txt_i="10978" txt_f="10987">2 (6.25%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19553" xml_f="19562" txt_i="10988" txt_f="10997">1 (3.13%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19610" xml_f="19612" txt_i="10998" txt_f="11000">32</offsets></td></tr></tbody></table></table-wrap></sec><sec id="S20008"><title><offsets xml_i="19681" xml_f="19708" txt_i="11002" txt_f="11029">Quality of life measurement</offsets></title><p><offsets xml_i="19719" xml_f="19877" txt_i="11030" txt_f="11188">After a series of MLD, in the MLD group the QoL improved regarding the symptoms, which decreased according to a point-based scale by 19.5% from 54.4 to 43.8 (</offsets><italic><offsets xml_i="19885" xml_f="19886" txt_i="11188" txt_f="11189">p</offsets></italic><offsets xml_i="19895" xml_f="19999" txt_i="11189" txt_f="11290"> &lt; 0.05). After surgery in the MLD group the average of symptoms further decreased by 12.8% to 38.2 (</offsets><italic><offsets xml_i="20007" xml_f="20008" txt_i="11290" txt_f="11291">p</offsets></italic><offsets xml_i="20017" xml_f="20083" txt_i="11291" txt_f="11354"> &lt; 0.05). In the control group it decreased from 51.9 to 38.7 (</offsets><italic><offsets xml_i="20091" xml_f="20092" txt_i="11354" txt_f="11355">p</offsets></italic><offsets xml_i="20101" xml_f="20214" txt_i="11355" txt_f="11465"> &lt; 0.05). No statistically significant differences between the MLD group and the control group were observed (</offsets><xref ref-type="fig" rid="F0003"><offsets xml_i="20247" xml_f="20255" txt_i="11465" txt_f="11473">Figure 3</offsets></xref><offsets xml_i="20262" xml_f="20363" txt_i="11473" txt_f="11574">). In both groups the subjective evaluation of degree of symptoms experienced by patients decreased (</offsets><italic><offsets xml_i="20371" xml_f="20372" txt_i="11574" txt_f="11575">p</offsets></italic><offsets xml_i="20381" xml_f="20393" txt_i="11575" txt_f="11584"> &lt; 0.05).</offsets></p><p><offsets xml_i="20400" xml_f="20776" txt_i="11585" txt_f="11961">In the MLD group the average degree of symptoms experienced after MLD decreased by 14% from 57.3 to 49.3. After surgery it further decreased by 12.6% to 43.1. In the control group, the average degree of symptoms experienced after surgery decreased by 24.4% from 53.7 to 40.6. No statistically significant differences between the MLD group and the control group were observed (</offsets><xref ref-type="fig" rid="F0003"><offsets xml_i="20809" xml_f="20817" txt_i="11961" txt_f="11969">Figure 3</offsets></xref><offsets xml_i="20824" xml_f="20826" txt_i="11969" txt_f="11971">).</offsets></p><fig id="F0003" position="float"><label><offsets xml_i="20870" xml_f="20878" txt_i="11972" txt_f="11980">Figure 3</offsets></label><caption><p><offsets xml_i="20898" xml_f="20961" txt_i="11980" txt_f="12043">Comparison of average values of symptoms and their significance</offsets></p></caption><graphic xlink:href="AMS-9-20876-g003"></graphic></fig></sec><sec id="S20009"><title><offsets xml_i="21060" xml_f="21093" txt_i="12045" txt_f="12078">Venous refilling time measurement</offsets></title><p><offsets xml_i="21104" xml_f="21189" txt_i="12079" txt_f="12164">In both groups no statistically significant differences were observed after surgery (</offsets><xref ref-type="fig" rid="F0004"><offsets xml_i="21222" xml_f="21230" txt_i="12164" txt_f="12172">Figure 4</offsets></xref><offsets xml_i="21237" xml_f="21239" txt_i="12172" txt_f="12174">).</offsets></p><fig id="F0004" position="float"><label><offsets xml_i="21283" xml_f="21291" txt_i="12175" txt_f="12183">Figure 4</offsets></label><caption><p><offsets xml_i="21311" xml_f="21343" txt_i="12183" txt_f="12215">Comparison of average VRT values</offsets></p></caption><graphic xlink:href="AMS-9-20876-g004"></graphic></fig></sec><sec id="S20010"><title><offsets xml_i="21442" xml_f="21473" txt_i="12217" txt_f="12248">Foot volumetry (FV) measurement</offsets></title><p><offsets xml_i="21484" xml_f="21576" txt_i="12249" txt_f="12341">In the MLD group after a series of MLD the average of FV decreased from 3625 ml to 3472 ml (</offsets><italic><offsets xml_i="21584" xml_f="21585" txt_i="12341" txt_f="12342">p</offsets></italic><offsets xml_i="21594" xml_f="21728" txt_i="12342" txt_f="12473"> &lt; 0.05) and after surgery it was 3418 ml. In the control group after surgery the average of FV decreased from 3581 ml to 3559 ml (</offsets><italic><offsets xml_i="21736" xml_f="21737" txt_i="12473" txt_f="12474">p</offsets></italic><offsets xml_i="21746" xml_f="21804" txt_i="12474" txt_f="12529"> &lt; 0.05). In the MLD group the improvement was higher (</offsets><italic><offsets xml_i="21812" xml_f="21813" txt_i="12529" txt_f="12530">p</offsets></italic><offsets xml_i="21822" xml_f="21861" txt_i="12530" txt_f="12566"> &lt; 0.01) than in the control group (</offsets><xref ref-type="fig" rid="F0005"><offsets xml_i="21894" xml_f="21902" txt_i="12566" txt_f="12574">Figure 5</offsets></xref><offsets xml_i="21909" xml_f="21911" txt_i="12574" txt_f="12576">).</offsets></p><fig id="F0005" position="float"><label><offsets xml_i="21955" xml_f="21963" txt_i="12577" txt_f="12585">Figure 5</offsets></label><caption><p><offsets xml_i="21983" xml_f="22014" txt_i="12585" txt_f="12616">Comparison of average FV values</offsets></p></caption><graphic xlink:href="AMS-9-20876-g005"></graphic></fig></sec></sec><sec sec-type="discussion" id="S0011"><title><offsets xml_i="22140" xml_f="22150" txt_i="12619" txt_f="12629">Discussion</offsets></title><p><offsets xml_i="22161" xml_f="22603" txt_i="12630" txt_f="13072">In 2008, the guidelines of the expert group headed by Nicolaides concerning classification, diagnostics and treatment of CVD were published. Evaluation of QoL was presented as an important tool in the analysis of treatment results. QoL questionnaires, such as CIVIQ, VCSS, SF-36, and HAD, were considered as very useful and credible in evaluation of disease severity and in evaluation of conservative treatment as well as surgical treatment [</offsets><xref ref-type="bibr" rid="CIT0006"><offsets xml_i="22639" xml_f="22640" txt_i="13072" txt_f="13073">6</offsets></xref><offsets xml_i="22647" xml_f="22649" txt_i="13073" txt_f="13075">].</offsets></p><p><offsets xml_i="22656" xml_f="22967" txt_i="13076" txt_f="13387">In conservative treatment of CVD methods such as elimination of risk factors, pharmacotherapy, compression therapy or physical exercise have a well-proven track record, whereas MLD has not achieved the position it deserves yet. There are not many publications concerning the role of MLD in the treatment of CVD.</offsets></p><p><offsets xml_i="22974" xml_f="23428" txt_i="13388" txt_f="13842">Research has proven that MLD applied in patients with CVD improves clinical stage, hemodynamic parameters and QoL. In evaluation of disease severity in patients with CVD, significant improvement of clinical stage was observed after MLD. The average value of clinical stage according to CEAP improved by 3.6%. We observed significant improvement of lower limb and foot volumes. After 10 days of MLD the volumes of foot and lower limb decreased by 153 ml (</offsets><italic><offsets xml_i="23436" xml_f="23437" txt_i="13842" txt_f="13843">p</offsets></italic><offsets xml_i="23446" xml_f="23629" txt_i="13843" txt_f="14023"> &lt; 0.05) on average. The mean of the QoL parameter regarding symptoms decreased by 19.5%, and the mean of the QoL parameter regarding the significance of symptoms decreased by 14%.</offsets></p><p><offsets xml_i="23636" xml_f="24091" txt_i="14024" txt_f="14479">In earlier studies it was proven that after performance of MLD in patients with CVD, the average of clinical parameter C according to the CEAP classification improved from 3.6 to 1.5. Using the HAD questionnaire, we proved that CVD causes anxiety and depressive states, and MLD improved QoL by decreasing these symptoms. The average of anxiety states after MLD decreased from 12.8 to 4.9. The average of depressive states also decreased, from 9.4 to 3.0 [</offsets><xref ref-type="bibr" rid="CIT0007"><offsets xml_i="24127" xml_f="24128" txt_i="14479" txt_f="14480">7</offsets></xref><offsets xml_i="24135" xml_f="24137" txt_i="14480" txt_f="14482">].</offsets></p><p><offsets xml_i="24144" xml_f="24150" txt_i="14483" txt_f="14489">Felty </offsets><italic><offsets xml_i="24158" xml_f="24163" txt_i="14489" txt_f="14494">et al</offsets></italic><offsets xml_i="24172" xml_f="24429" txt_i="14494" txt_f="14751">. emphasized that compression therapy has been used in the treatment of CVD for over 2000 years. In order to improve the effectiveness of this method, he used intermittent compression and MLD. The connection of these two methods caused a decrease of edema [</offsets><xref ref-type="bibr" rid="CIT0008"><offsets xml_i="24465" xml_f="24466" txt_i="14751" txt_f="14752">8</offsets></xref><offsets xml_i="24473" xml_f="24475" txt_i="14752" txt_f="14754">].</offsets></p><p><offsets xml_i="24482" xml_f="24589" txt_i="14755" txt_f="14862">A beneficial influence of MLD on the effects of treatment in patients with CVD was observed by Evrard-Bras </offsets><italic><offsets xml_i="24597" xml_f="24602" txt_i="14862" txt_f="14867">et al</offsets></italic><offsets xml_i="24611" xml_f="24954" txt_i="14867" txt_f="15210">. They proved that skin care, banding according to the rule of gradual compression and appropriate physical exercise prolong the effects of MLD. They claim that the main indications for MLD are: CVD, primary and secondary lymphatic edema, and post-injury conditions. However, it seems controversial to recommend MLD in thromboembolic disease [</offsets><xref ref-type="bibr" rid="CIT0009"><offsets xml_i="24990" xml_f="24991" txt_i="15210" txt_f="15211">9</offsets></xref><offsets xml_i="24998" xml_f="25000" txt_i="15211" txt_f="15213">].</offsets></p><p><offsets xml_i="25007" xml_f="25095" txt_i="15214" txt_f="15302">Foldi reported the ineffectiveness of MLD without compression therapy in their studies [</offsets><xref ref-type="bibr" rid="CIT0010"><offsets xml_i="25131" xml_f="25133" txt_i="15302" txt_f="15304">10</offsets></xref><offsets xml_i="25140" xml_f="25289" txt_i="15304" txt_f="15453">]. Grądalski and Ochałek claim that it is essential to simultaneously perform compression therapy in order to prolong the anti-edema effects of MLD [</offsets><xref ref-type="bibr" rid="CIT0011"><offsets xml_i="25325" xml_f="25327" txt_i="15453" txt_f="15455">11</offsets></xref><offsets xml_i="25334" xml_f="25336" txt_i="15455" txt_f="15457">].</offsets></p><p><offsets xml_i="25343" xml_f="25761" txt_i="15458" txt_f="15876">Rowland examined the use of pneumatic compression as an alternative to compression bandage in patients with venous ulcer. Patients were divided into 2 groups. As the pressure of the pneumatic compression device is constant, reduction of edema was equal in both groups during the period when edema was greatest; however, in the progressive aspect, a greater reduction in edema volume was observed in the bandage group [</offsets><xref ref-type="bibr" rid="CIT0012"><offsets xml_i="25797" xml_f="25799" txt_i="15876" txt_f="15878">12</offsets></xref><offsets xml_i="25806" xml_f="25808" txt_i="15878" txt_f="15880">].</offsets></p><p><offsets xml_i="25815" xml_f="25855" txt_i="15881" txt_f="15921">A meta-analysis study prepared by Karki </offsets><italic><offsets xml_i="25863" xml_f="25868" txt_i="15921" txt_f="15926">et al</offsets></italic><offsets xml_i="25877" xml_f="25925" txt_i="15926" txt_f="15974">. also showed that MLD alone was not effective [</offsets><xref ref-type="bibr" rid="CIT0013"><offsets xml_i="25961" xml_f="25963" txt_i="15974" txt_f="15976">13</offsets></xref><offsets xml_i="25970" xml_f="25982" txt_i="15976" txt_f="15988">]. Szewczyk </offsets><italic><offsets xml_i="25990" xml_f="25995" txt_i="15988" txt_f="15993">et al</offsets></italic><offsets xml_i="26004" xml_f="26408" txt_i="15993" txt_f="16397">. proved the effectiveness of MLD in decreasing edema of lower limbs in patients with CVD. In a group of 15 patients, who had MLD performed twice a week for a period of 3 weeks, they evaluated the results of treatment on the basis of lower limbs perimeter measurement. They observed a decrease of edema compared to the initial condition on average by 2.2 cm around the ankles and 1.7 cm around the calf [</offsets><xref ref-type="bibr" rid="CIT0014"><offsets xml_i="26444" xml_f="26446" txt_i="16397" txt_f="16399">14</offsets></xref><offsets xml_i="26453" xml_f="26455" txt_i="16399" txt_f="16401">].</offsets></p><p><offsets xml_i="26462" xml_f="26741" txt_i="16402" txt_f="16681">The MLD is an easy therapeutic method but it requires a high level of technical ability to be applied successfully. In this way, this method gives really good results especially in congenital and acquired lymphedema, CVD, and some general diseases such as headaches and colitis [</offsets><xref ref-type="bibr" rid="CIT0015"><offsets xml_i="26777" xml_f="26779" txt_i="16681" txt_f="16683">15</offsets></xref><offsets xml_i="26786" xml_f="26788" txt_i="16683" txt_f="16685">].</offsets></p><p><offsets xml_i="26795" xml_f="27421" txt_i="16686" txt_f="17312">Despite a relatively small number of patients, this study proves that application of MLD before surgery of varicose veins improves the effect of the surgical treatment. Comparative analysis in the studied groups showed better results as regards the disease severity, as well as hemodynamic parameters (foot volumetry) and QoL. As regards the point-based value of disease severity, more significant improvement was observed in the MLD group than in the control group. However, this difference was not statistically significant. There was a statistically significant difference between both groups in foot volumetry measurement.</offsets></p><p><offsets xml_i="27428" xml_f="27926" txt_i="17313" txt_f="17811">Our earlier studies proved that there were better effects of surgical treatment, as far as decrease of anxiety and depressive states caused by varicose veins are concerned, in a group of patients who underwent MLD before surgery. The average of anxiety states, as well as the average of depressive states, decreased more significantly in the MLD group than in the control group. These results were positively correlated with the results obtained in clinical examination and hemodynamic test (VRI) [</offsets><xref ref-type="bibr" rid="CIT0007"><offsets xml_i="27962" xml_f="27963" txt_i="17811" txt_f="17812">7</offsets></xref><offsets xml_i="27970" xml_f="27972" txt_i="17812" txt_f="17814">].</offsets></p><p><offsets xml_i="27979" xml_f="27985" txt_i="17815" txt_f="17821">Bakar </offsets><italic><offsets xml_i="27993" xml_f="27998" txt_i="17821" txt_f="17826">et al</offsets></italic><offsets xml_i="28007" xml_f="28773" txt_i="17826" txt_f="18592">. performed a study in 62 patients, aged 59 to 68 years (mean 64.95 ±2.54 years), with chronic venous disease treated with complex decongestive physiotherapy (CDP). The study results proved that CDP can statistically significantly reduce the volume and percentage volume of CVI-related edema and reduce the intensity of pain caused by this condition in older people. According to the authors, further controlled studies should include a greater number of cases, subjective and objective comparison of MLD outcomes, intermittent pneumatic compression, exercise, the use of compression alone, and comparison with the gold standard for CDP in terms of both short- and long-term results, using objective signs such as pre- and post-treatment Doppler ultrasound results [</offsets><xref ref-type="bibr" rid="CIT0016"><offsets xml_i="28809" xml_f="28811" txt_i="18592" txt_f="18594">16</offsets></xref><offsets xml_i="28818" xml_f="28820" txt_i="18594" txt_f="18596">].</offsets></p><p><offsets xml_i="28827" xml_f="29542" txt_i="18597" txt_f="19312">The surgical treatment of CVD in the lower limbs, whether it is a case of so-called ‘essential’ varices or of post-phlebitic disorders, presents a certain number of risks of venous thrombosis and especially of cutaneous necrosis or of cicatricial detachment in operations of the Lindon or Felder type. Given a less significant set-back, it has been suggested that restorative surgery of the deep venous network, valve repair or insertion of a valvulated section should be used in the treatment of post-phlebitic illness. Promising results have been obtained through specific kinesitherapy, involving a Leduc type MLD together with pressotherapy, in the preparation of patients and in post-operative follow-up care [</offsets><xref ref-type="bibr" rid="CIT0017"><offsets xml_i="29578" xml_f="29580" txt_i="19312" txt_f="19314">17</offsets></xref><offsets xml_i="29587" xml_f="29589" txt_i="19314" txt_f="19316">].</offsets></p><p><offsets xml_i="29596" xml_f="29746" txt_i="19317" txt_f="19467">The results obtained in this study on the use of MLD in treatment of patients with CVD are comparable with the results obtained by other researchers [</offsets><xref ref-type="bibr" rid="CIT0007"><offsets xml_i="29782" xml_f="29783" txt_i="19467" txt_f="19468">7</offsets></xref><offsets xml_i="29790" xml_f="29792" txt_i="19468" txt_f="19470">, </offsets><xref ref-type="bibr" rid="CIT0014"><offsets xml_i="29828" xml_f="29830" txt_i="19470" txt_f="19472">14</offsets></xref><offsets xml_i="29837" xml_f="30212" txt_i="19472" txt_f="19847">]. The beneficial influence of MLD on the improvement of clinical and hemodynamic parameters and on the improvement of QoL has been confirmed in patients undergoing conservative treatment as well as in those who underwent varicose vein surgery. This allows us to assume that MLD is an effective method complementing the methods of CVD treatment that have been used until now.</offsets></p><p><offsets xml_i="30219" xml_f="30677" txt_i="19848" txt_f="20306">In conclusion, manual lymphatic drainage decreases the degree of disease severity and foot and lower limb volume in patients with chronic venous disease, as well as improving their quality of life. Manual lymphatic drainage applied in patients with chronic venous disease pre-operatively provides better effects of treatment, which is manifested by a decrease in the degree of disease severity, foot and lower limb volume, and improvement of quality of life.</offsets></p></sec></body><back><ref-list><title>References</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloviczki</surname><given-names>P</given-names></name><name><surname>Comerota</surname><given-names>AJ</given-names></name><name><surname>Dalsing</surname><given-names>MC</given-names></name><etal></etal></person-group><article-title>The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum</article-title><source>J Vasc Surg</source><year>2011</year><volume>53</volume><issue>5 Suppl</issue><fpage>2S</fpage><lpage>48S</lpage><pub-id pub-id-type="pmid">21536172</pub-id></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biemans</surname><given-names>AA</given-names></name><name><surname>van der Velden</surname><given-names>SK</given-names></name><name><surname>Bruijninckx</surname><given-names>CM</given-names></name><name><surname>Buth</surname><given-names>J</given-names></name><name><surname>Nijsten</surname><given-names>T</given-names></name></person-group><article-title>Validation of the chronic venous insufficiency quality of life questionnaire in dutch patients treated for varicose veins</article-title><source>Eur J Vasc Endovasc Surg</source><year>2011</year><volume>42</volume><fpage>246</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">21531589</pub-id></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jawień</surname><given-names>A</given-names></name><name><surname>Szewczyk</surname><given-names>MT</given-names></name><name><surname>Kędziora-Kornatowska</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Functional and biopsychosocial restrictions among patients with a venous ulcer</article-title><source>Arch Med Sci</source><year>2006</year><volume>2</volume><fpage>36</fpage><lpage>41</lpage></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bączyk</surname><given-names>G</given-names></name><name><surname>Talarska</surname><given-names>D</given-names></name><name><surname>Zawirska</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Functioning and quality of life of patients with leg ulcers treated at dermatology wards</article-title><source>Postep Derm Alergol</source><year>2011</year><volume>28</volume><fpage>191</fpage><lpage>6</lpage></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Földi</surname><given-names>M</given-names></name><name><surname>Strößenreuther</surname><given-names>R</given-names></name></person-group><source>Treatment of the leg. Foundations of manual lymph drainage</source><year>2005</year><edition>3rd ed</edition><publisher-name>Elsevier Mosby</publisher-name></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolaides</surname><given-names>AN</given-names></name><name><surname>Allegra</surname><given-names>C</given-names></name><name><surname>Bergan</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence</article-title><source>Int Angiol</source><year>2008</year><volume>27</volume><fpage>1</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">18277340</pub-id></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molski</surname><given-names>P</given-names></name><name><surname>Ossowski</surname><given-names>R</given-names></name><name><surname>Hagner</surname><given-names>W</given-names></name><name><surname>Molski</surname><given-names>S</given-names></name></person-group><article-title>Patients with venous disease benefit from manual lymphatic drainage</article-title><source>Int Angiol</source><year>2009</year><volume>28</volume><fpage>151</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">19367246</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felty</surname><given-names>CL</given-names></name><name><surname>Rooke</surname><given-names>TW</given-names></name></person-group><article-title>Compression therapy for chronic venous insufficiency</article-title><source>Semin Vasc Surg</source><year>2005</year><volume>18</volume><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">15791552</pub-id></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evrard-Bras</surname><given-names>M</given-names></name><name><surname>Coupe</surname><given-names>M</given-names></name><name><surname>Laroche</surname><given-names>JP</given-names></name><etal></etal></person-group><article-title>Manual lymphatic drainage</article-title><source>Rev Prat</source><year>2000</year><volume>50</volume><fpage>1199</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">11008500</pub-id></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foldi</surname><given-names>E</given-names></name></person-group><article-title>The treatment of lymphedema</article-title><source>Cancer</source><year>1998</year><volume>83</volume><fpage>2833</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9874407</pub-id></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochałek</surname><given-names>K</given-names></name><name><surname>Grądalski</surname><given-names>T</given-names></name></person-group><article-title>Manual Lymph Drainage usage in vascular diseases</article-title><source>Acta Angiologica</source><year>2011</year><volume>3</volume><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>J</given-names></name></person-group><article-title>Intermittent pump versus compression bandages in the treatment of venous leg ulcers</article-title><source>Aust N Z J Surg</source><year>2000</year><volume>70</volume><fpage>110</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">10711472</pub-id></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karki</surname><given-names>A</given-names></name><name><surname>Anttila</surname><given-names>H</given-names></name><name><surname>Tasmuth</surname><given-names>T</given-names></name><name><surname>Rautakorpi</surname><given-names>UM</given-names></name></person-group><article-title>Lymphoedema therapy in breast cancer patients: a systematic review on effectiveness and a survey of current practices and costs in Finland</article-title><source>Acta Oncol</source><year>2009</year><volume>48</volume><fpage>850</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19235573</pub-id></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szewczyk</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>The importance of massage in edema of lower limbs in patients with chronic venous insufficiency</article-title><source>Valetudinaria. Postƙpy Medycyny Klinicznej i Wojskowej</source><year>2002</year><volume>7</volume><fpage>50</fpage><lpage>3</lpage></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traissac</surname><given-names>B</given-names></name><name><surname>Sagardoy</surname><given-names>G</given-names></name><name><surname>Lucas</surname><given-names>JF</given-names></name></person-group><article-title>Manual lymphatic drainage in angiology</article-title><source>Phlebologie</source><year>1988</year><volume>41</volume><fpage>471</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3406106</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakar</surname><given-names>Y</given-names></name><name><surname>Ozturk</surname><given-names>A</given-names></name><name><surname>Calisal</surname><given-names>M</given-names></name><name><surname>Erturk</surname><given-names>K</given-names></name><name><surname>Daglar</surname><given-names>B</given-names></name></person-group><article-title>Complete decongestive physiotherapy for older people with chronic venous insufficiency</article-title><source>Topics in Geriatric Rehabilitation</source><year>2010</year><volume>26</volume><fpage>164</fpage><lpage>70</lpage></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valentin</surname><given-names>J</given-names></name><name><surname>Léonhardt</surname><given-names>D</given-names></name><name><surname>Perrin</surname><given-names>M</given-names></name></person-group><article-title>Prevention of venous thromboses and cutaneous necroses using physical methods and pressure therapy in the surgery of chronic venous insufficiency of the lower limbs</article-title><source>Phlebologie</source><year>1988</year><volume>41</volume><fpage>690</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3222320</pub-id></element-citation></ref></ref-list></back></article>